We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Canakinumab in Patients With COVID-19 and Type 2 Diabetes (CanCovDia)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04510493
Recruitment Status : Completed
First Posted : August 12, 2020
Last Update Posted : September 8, 2021
Sponsor:
Collaborators:
Novartis
Swiss National Science Foundation
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland